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Abstract
Objective: To assess the utility of liver function tests (LFTs) for early recognition and 
prediction of severity of dengue fever in hospitalized patients. Study Design: An ana-
lytical study. Place and duration of study: Services Institute of Medical Science and Fatima 
Memorial Hospital, Lahore, from September to December 2010. Methodology: Admitted 
cases of dengue fever were divided into three groups: mild, moderate, and severe 
increases in aminotransferases. Elevation in LFTs was co-related with good or bad out-
come i.e. (survival or complication free stay) or (death or complications). Results were 
analyzed in SPSS version 18. Results: Out of the 353 patients with mean age of 37.12 ± 
15.45 years, 245 (69.4%) were males and 108 (30.6%) were females. Seventy five patients 
(21.2%) had mild elevation of aminotransferases (twofold increases), 265 patients (75.1%) 
had moderate increases (three to fourfold), and 13 (3.7%) had severe (>4 fold increase). 
Alanine transaminase (ALT) was statistically higher in patients with septicemia, hepatic, 
and renal failure (p-value ≤0.05). Aspartate transaminase (AST) was higher in almost all 
complications. Prolonged hospital stay was associated with raised LFTs and greater com-
plications and mortality. AST was found to be twice as much raised as ALT. Conclusion: 
AST and ALT were statistically higher in patients with worse outcome thus can lead to 
early recognition of high risk cases.
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1. Definition of subject area
Dengue fever has emerged as a biggest global pandemic caused by a flavivirus with signifi-
cant impact on the disease burden in population living in tropical countries with 1–2 epidemics 
every year [1].
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1.1. Dengue virus
Dengue virus (DENV) has four serotypes (DEN 1–4). Currently, all the serotypes have 
 diffused in tropical and subtropical regions of the world [2].
1.2. Mode of transmission
DENVs are transmitted via the female mosquito species Aedes Aegypti and less commonly by 
Aedes Albopictus [2].
1.3. Incubation period
Dengue virus has an incubation period of 3–10 days with average of 5–6 days [3].
1.4. Period of infectivity
Within first 5 days of illness, if Aedes mosquito feeds on patient blood, it will become infec-
tive [3].
1.5. Outcome of dengue infection
Majority of dengue infections are asymptomatic. Among symptomatic presentation is highly 
variable from mild flu-like illness to classical dengue fever (DF) (bone-break fever) and even 
some complicate into dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), 
which are life threatening (Table 1) [4].
If total score >6, then patient has high chances of having dengue fever
• This scoring system carries
• sensitivity = 90.7%
• specificity = 86.9%
• positive predictive value = 81.4%
• negative predictive value = 93.6%.
• Chang et al. [5].
2. Description of study
Involvement of liver with deranged liver function tests (LFTs) is likely with dengue fever and 
which may include mildly raised in serum total bilirubin, increased alanine transaminase 
(ALT) and aspartate transaminase (AST), and decreased in serum albumin which can be a 
used as a prognostic indicator [6].
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3. Objectives of the study
The objectives of the chapter are as follows:
1. To evaluate such alterations in the liver function test as an early marker for severity and 
timely diagnosis of dengue fever complications and severity [7].
2. To identify patients who might develop severe complications.
3. To decrease the degree of in hospital stay by categorizing patients into mild, moderate, 
and high risk groups according to their raised transaminases (ALT and AST) levels [8].
4. Materials and methods
A study was conducted in different government as well as private tertiary care setups in 
Lahore from September 2010 to December 2010. The total 353 patients were included in the 
study. It was a simple randomized sample and the study design was a cross-sectional obser-
vational study.
4.1. Categorization of patients
Patients were divided into three groups and categorized to have mild, moderate, or severe liver 
dysfunction. Group I included patients who had twofold or lesser increase in liver enzymes; in 
1 Epidemiology Score
Recent travel to Southeast Asia or four endemic dengue fever in Taiwan within 1 week 4
2 Clinical symptom
Skin rash 3
Bleeding signs (Included petechia, gum bleeding, epistaxis, gastrointestinal bleeding, 
hemoptysis, hematuria, and menorrhagia)
3
Fever 2
Headache, retrobulbar pain, bone pain, myalgia 1
GI symptoms (poor appetite, abdominal pain, diarrhea and nausea) 1
Absence of cough and rhinorrhea 1
3 Differential diagnosis
Fever > 7 days −8
Identified infection focus (e.g., Eschar of scrub typhus and upper respiratory infection) −10
Table 1. Diagnostic criteria for dengue fever.
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group II patients, liver function tests were between twofold and fourfold greater than normal; 
group III patients had liver function tests greater than fourfold above normal. The correlation 
of these groups with the development of complications, mortality, and number of days of hos-
pital stay was studied. Good outcome was taken as survival and complication free pattern of 
disease, while bad outcome was taken as development of complication or mortality.
4.2. Results and conclusion
• The effects of dengue fever on liver are usually asymptomatic but can be atypical and have var-
ied severity. From asymptomatic elevated transaminase levels to fulminant hepatic failure, the 
variable manifestations are a big challenge to the clinicians treating the condition (Tables 2–4).
The reversal of alanine transaminase and aspartate transaminase (ALT to AST) ratio observed 
in dengue fever as compared to that seen in other viral hepatitis can lead to an early diagnosis 
of these patients.
• Increasing trend in aminotransferases is associated with major complications and a bad 
outcome as compared to patients with mild or moderate hepatic dysfunction.
• Severe hepatitis and specifically raised alanine transaminase (ALT) levels are a poor prog-
nostic indicator of outcome in dengue fever.
Variables Mean Std. deviation Minimum Maximum
Age (years) 37.12 15.456 4 80
Duration of fever 5.49 2.64 1 35
Table 2. Descriptive statistics of demographical variables.
Complications Severity of disease Total n = 85
Mild n = 27 Moderate n = 38 Severe n = 20
DHF 12 (14. 11%) 11 (12.94%) 1 (1.17%) 24 (28.23%)
DSS 4 (4.7%) 4 (4.7%) 4 (4.7%) 12 (14.11%)
Hemorrhage 8 (9.41%) 18 (21.17%) 3 (3.52%) 29 (34.11%)
Septicemia 0 (0%) 2 (2.35%) 3 (3.52%) 5 (5.88%)
Hepatic failure 0 (0%) 1 (1.17%) 4 (4.7%) 5 (5.88%)
Encephalopathy 2 (2.35%) 1 (1.17%) 1 (1.17%) 4 (4.70%)
Respiratory failure 1 (1.17%) 1 (1.17%) 2 (2.35%) 4 (4.70%)
Renal failure 0 (0%) 0 (0%) 2 (2.35%) 2 (2.35%)
Total 27 (31.76%) 38 (44.70%) 20 (23.52%) 85
Table 3. Complications versus severity of disease.
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• The younger age group of patients was directly associated with severely raised levels of 
alanine transaminase (ALT) and thus contributing to a higher mortality.
4.3. Pathogenesis of DF, DHF, and DSS
Dengue virus presumably affects the reticulo-endothelial system of the body in skin, lymph 
nodes, spleen, marrow and liver [9].
DHF and DSS are caused by disorder of the immune system. In recovery phase (days 7–14) of 
first infection, another serotype is superinfected. Then antibodies against first serotype binds 
with new entrant serotype antigen leading to immune complex formation, their deposition 
on endothelium leading to widespread vessel wall injury, hemorrhages, and third spacing of 
fluid [4].
4.4. Dengue virus and liver
The dengue virus affects the liver but mostly, liver involvement is usually subclinical. But it 
can still lead to acute fulminant hepatic failure in dengue-affected countries. Dengue should 
be a differential in management of acute fulminant hepatic failure and as a triggering factor 
in patient with acute on chronic liver failure [6].
Despite being asymptomatic in majority of cases, clinical presentation like acute hepatitis and 
even acute fulminant liver failure may rarely appear as a complication.
4.5. Pathogenesis of liver injury
Hepatic dysfunction is a crucial feature seen in DENV infection. Hepatocytes and Kupffer cells 
are prime targets for DENV infection. Pathogenesis of hepatic injury in dengue is believed 
to be primarily a T cell-mediated process involving interaction between antibodies and the 
endothelium and a concomitant cytokine storm [7, 10].
4.6. Liver morphology
Liver biopsy and microscopy reveals fatty change (microvesicular) along with hepatocyte 
necrosis and hyperplasia. Additionally, there is mononuclear cell infiltration at the portal 
tract along with destruction of Kupffer cells and Councilman bodies [11].
Tests result Mean Std. deviation Minimum Maximum
TLC 4.7711 2.17496 1 20
ALT 100.29 102.14 11 1102
AST 234.17 136.09 21 1680
PT 16.71 3.59 10 60
APTT 34.40 1.650 19 50
Table 4. Descriptive statistics of different investigations.
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Hepatocyte damage with necrotic changes mostly starts with midzonal area and then spreads 
to centrilobular area. As these particular areas are more sensitive to anoxic or immune- 
mediated injury [7, 8].
5. Clinical presentation with liver involvement in dengue fever
Clinical evidence suggests that dengue-related hepatic involvement incudes the presence of 
liver enlargement. Among the clinical features of hepatic involvement, patients have abdomi-
nal pain (18–63%) and nausea/vomiting (49–58%). Abdominal pain and anorexia are more 
common in DF than DHF [12].
Hepatomegaly can be seen in both DF and DHF but more common in DF. The incidence of 
hepatomegaly in the adult patients varies from 4 to 52%. Clinical jaundice has been found in 
only 1.7–17%, and hyperbilirubinemia has been found to be as high as 48% [13, 14].
5.1. Biochemical picture of liver (LFTs) in dengue fever
The most common abnormality has been raised transaminases levels. The raised aspartate 
transaminase (AST) levels are found around 63–97% of patients, whereas the elevated alanine 
transaminase (ALT) levels are found in 45–96% of patients [8].
Studies have shown in majority of cases that aspartate transaminase (AST) is usually more 
raised than alanine transaminase (ALT), more during the early infection, especially within 
first week and then declining to normal levels in next 3 weeks. Aspartate transaminase (AST) 
is more raised than alanine transaminase (ALT), the additional aspartate transaminase (AST) 
is released from damaged myocyte.
The reversal of alanine transaminase and aspartate transaminase (AST/ALT) ratio is helpful to 
differentiate it from other acute viral hepatitis like HAV, HBV, HCV, etc., where this is rarely 
seen except in alcoholic hepatitis [6].
The average levels of aspartate transaminase (AST) ranged from 93.3 to 174 U/L while alanine 
transaminase (ALT) from 86 to 88.5 U/L. The level of increase in hepatic transaminases can 
easily mimic acute viral hepatitis.
5.2. Role of transaminases as marker of severity of dengue fever
The median aspartate transaminase (AST) and alanine transaminase (ALT) values have been 
found to be higher for severer forms of dengue than for uncomplicated dengue fever [15].
This hints at a possible association between increased transaminase levels with increasing dis-
ease severity. Interestingly, the values of liver enzymes were noted to be higher in the febrile 
and the severer phases of dengue fever.
Aspartate transaminase (AST) has various sources including the heart, striated muscle, eryth-
rocytes, etc., apart from the liver, whilst alanine transaminase (ALT) primarily is hepatic in 
origin. Therefore, rise in aspartate transaminase (AST) might not be a true reflection of hepatic 
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involvement. Moreover, patients with high levels of enzymes may be labeled as severe dis-
ease without any effect on the final outcomes [16].
Hypoproteinemia or hypoalbuminemia ranges from 16.5 to 76%. The heterogeneity in the 
population and severity of the disease may be responsible for such a wide range.
Coagulation abnormalities have been found in multiple studies. International normalized 
ratio (INR) > 1.5 have been found in 11% of patients, while abnormal prothrombin time (PT), 
partial thromboplastin time noted in 34–42.5% of the cases [17].
Increasing bleeding episodes have been seen with increasing alanine transaminase and aspar-
tate transaminase (AST/ALT) levels, but correlation between PT and transaminase levels is 
not found to be strong during the recovery period, which means liver synthetic function like 
clotting factor production is usually well preserved.
Liver involvement comes commonly and with more severity in children as compared to 
adults [18]. Treatment is primarily supportive, and the prognosis is usually good. Differential 
diagnosis and hepatotoxic drugs should be avoided [19].
5.3. Suggestions
Liver function tests should be used as routine initial part of the investigative studies in a 
patient with suspected dengue fever.
Serial monitoring of liver function tests, especially alanine transaminase (ALT), should be 
done to identify high-risk cases.
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